Heart disease kills more Americans than any other condition, about 700,000 per year. Yet despite decades of progress in treatment, approaches to prevention remain largely reactive. Here’s a common pathway: wait for a patient to reach middle age, find their cholesterol numbers alarming, then act. New guidelines released Friday by the American College of Cardiology, the American Heart Association and nine other medical societies propose updating that model.

For the first time, the threshold for considering a "statin" — medications to reduce cholesterol and lower heart disease risk in a broad group of patients — has been pushed back to age 30. Earlier guidelines suggested using 40 as an age threshold. The new guidance also recommends checking cholesterol as young as age 9-11 and running lipid panels for patients in their 20s.

To be clear, this doesn’t mean every 30-year-old needs to run out and take cholesterol pills. What it does mean is that early screening for cholesterol levels is now even more important, and if a young person has high cholesterol and risk factors, waiting another 10 years to intervene may mean missing the window to prevent long-term damage.

Who Might Be Recommended A Statin In Their 30s?

The new guidelines address younger adults aged 30 to 39 whose LDL cholesterol, the so-called “bad cholesterol,” reaches 160 mg/dL or higher.

In this group, the first line is always lifestyle modification: improving diet, increasing physical activity and managing weight. Yet now, a statin may be considered alongside or in addition to lifestyle efforts when a person’s calculated 30-year cardiovascular risk score reaches 10% or higher.

875 Million Android Phones Put At Risk From 60 Second Hack

Google Zero-Day Alert For 3.5 Billion Chrome Users—Attacks Underway

Apple iPhone 18 Pro Price Detailed In New Report

Risk-enhancing factors also can tip the scales toward earlier pharmacological treatment in this........

© Forbes